cystic fibrosis

  1. Proteostasis Therapeutics stock reached double digits

    After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/
    • anonymous
    • Thread
    • astrazeneca biotech clinical trials cystic fibrosis fda novartis pharma proteostasis therapeutics vertex
    • Replies: 0
    • Forum: Pharma/Biotech Companies - In the News

  2. Vertex CF Portfolio Led To FY17 Expenses Forecast Lift

    $VRTX Vertex's cystic fibrosis portfolio progression has led the company to increase its guidance of combined R&D and SG&A for the full year 2017.
    • Mark Benson
    • Thread
    • cystic fibrosis earnings expenses guidance vertex
    • Replies: 0
    • Forum: Vertex
Top Bottom
Back